These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11576718)

  • 1. Dose intensive chemotherapy in small cell lung cancer.
    Wolf M
    Lung Cancer; 2001 Sep; 33 Suppl 1():S125-35. PubMed ID: 11576718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients.
    Woll PJ; Thatcher N; Lomax L; Hodgetts J; Lee SM; Burt PA; Stout R; Simms T; Davies R; Pettengell R
    J Clin Oncol; 2001 Feb; 19(3):712-9. PubMed ID: 11157022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-intensive therapy in lung cancer.
    Elias A
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S64-9. PubMed ID: 9272137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
    Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N
    J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn.
    Tjan-Heijnen VC; Wagener DJ; Postmus PE
    Ann Oncol; 2002 Oct; 13(10):1519-30. PubMed ID: 12377639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-intensive therapy in small cell lung cancer.
    Elias A
    Chest; 1998 Jan; 113(1 Suppl):101S-106S. PubMed ID: 9438698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
    Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
    Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell lung cancer: strategies to optimize chemotherapy response.
    Psyrri A; Murren J
    Cancer J; 2001; 7 Suppl 1():S28-34. PubMed ID: 11504283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.
    Souhami RL; Rudd R; Ruiz de Elvira MC; James L; Gower N; Harper PG; Tobias JS; Partridge MR; Davison AG; Trask C
    J Clin Oncol; 1994 Sep; 12(9):1806-13. PubMed ID: 8083704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer.
    Tjan-Heijnen VC; Postmus PE; Wagener DJ
    Anticancer Drugs; 1997 Jul; 8(6):549-64. PubMed ID: 9300569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy in small-cell lung cancer.
    Pasini F; Durante E; De Manzoni D; Rosti G; Pelosi G
    Anticancer Res; 2002; 22(6B):3465-72. PubMed ID: 12552940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
    Humblet Y; Symann M; Bosly A; Delaunois L; Francis C; Machiels J; Beauduin M; Doyen C; Weynants P; Longueville J
    J Clin Oncol; 1987 Dec; 5(12):1864-73. PubMed ID: 2824708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose-effect of chemotherapy in bronchial small-cell cancer].
    de Crevoisier R; le Cesne A; le Chevalier T
    Rev Mal Respir; 1997 Sep; 14(4):269-75. PubMed ID: 9411610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trials.
    Dowlati A; Crosby L; Remick SC; Makkar V; Levitan N
    Lung Cancer; 2001 May; 32(2):155-62. PubMed ID: 11325486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.
    Mascaux C; Paesmans M; Berghmans T; Branle F; Lafitte JJ; Lemaitre F; Meert AP; Vermylen P; Sculier JP;
    Lung Cancer; 2000 Oct; 30(1):23-36. PubMed ID: 11008007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group.
    Font A; Moyano AJ; Puerto JM; Tres A; Garcia-Giron C; Barneto I; Anton A; Sanchez JJ; Salvador A; Rosell R
    Cancer; 1999 Feb; 85(4):855-63. PubMed ID: 10091762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.
    Pujol JL; Daurès JP; Rivière A; Quoix E; Westeel V; Quantin X; Breton JL; Lemarié E; Poudenx M; Milleron B; Moro D; Debieuvre D; Le Chevalier T
    J Natl Cancer Inst; 2001 Feb; 93(4):300-8. PubMed ID: 11181777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for small-cell lung cancer: more is not better.
    Saka H; Shimokata K
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S107-9. PubMed ID: 9272144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-intensive therapy for small cell lung cancer.
    Elias AD
    Chest; 1995 Jun; 107(6 Suppl):261S-266S. PubMed ID: 7781403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.